Pfizer plans a $650 million, 220,000-square-foot center at its Groton campus to produce clinical active pharmaceutical ingredients and drug products for Pfizer-sponsored clinical trials worldwide.
Dedicated clinical manufacturing infrastructure will supply materials for Pfizer-sponsored trials and consolidate related campus operations.
Verify next: Construction commencement and progress toward the targeted mid-2031 operational startup.
Risk: The reviewed reporting does not quantify incremental output, identify equipment suppliers or confirm a procurement timetable.
Deere plans to consolidate sugar cane harvester production in Catalão, Brazil, in fiscal 2029, moving it from Thibodaux.
Deere says the move places production closer to the largest concentration of customer demand in South America and consolidates production at one location.
Verify next: A subsequent disclosure confirming the transfer and consolidated production in Catalão in fiscal 2029.
Risk: Thibodaux currently produces around 35 machines annually for the U.S. market.
Deere's Construction and Forestry Division is evaluating strategic sourcing opportunities across its operations.
The company says the review is intended to improve competitiveness and flexibility, manage costs and support investment in product development, technology, field sales and customer support.
Verify next: A subsequent company disclosure identifying sourcing actions, scope or outcomes.
Risk: No supplier, tender, award, purchase order or sourcing deadline was announced.